Aravind Eye Care System: Clinical Trials

14 trials sponsored by Aravind Eye Care System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 unknown, 2 recruiting, 1 active not recruiting. 7 Not applicable, 6 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 5, Unknown 2
Phase 36Completed 2, Recruiting 2, Active not recruiting 1, Not yet recruiting 1

Follow Aravind Eye Care System: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RB-PDT for Fusarium Keratitis: The LUMIERE Study
Rose Bengal Photodynamic Therapy, Sham RB-PDT - Fusarium Keratitis
Phase 3Not yet recruitingStanford University4342027-01-012026-08-17
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
Cyclosporine A, Placebo Comparator: Placebo - Fungal Keratitis, Corneal Ulcer
Phase 3RecruitingUniversity of California, San Francisco1502025-09-012026-06-05
Parasitic Ulcer Treatment Trial
Polyhexamethylene biguanide (PHMB), Topical corticosteroid, Topical placebo - Acanthamoeba Keratitis
Phase 3RecruitingJeremy Keenan, MD, MPH2322024-07-012026-10-01
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II
Difluprednate Ophthalmic, Rose Bengal, Moxifloxacin Ophthalmic - Bacterial Keratitis
Phase 3Active not recruitingUniversity of California, San Francisco602024-07-012026-08-17
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction
Moxifloxacin Ophthalmic, Chlorhexidine Gluconate, Natamycin - Acanthamoeba Keratitis, Fungal Keratitis
Phase 3CompletedUniversity of California, San Francisco3302022-08-032026-09-03
Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients
Nanodropper adaptor, Original eyedrop bottle/No Nanodropper - Glaucoma, Glaucoma, Open-Angle
Not applicableCompletedNanodropper, Inc.4202021-11-062023-01-18
Steroids and Cross-linking for Ulcer Treatment
Moxifloxacin Ophthalmic, Difluprednate Ophthalmic, Riboflavin Ophthalmic - Keratitis Bacterial
Phase 3CompletedThomas M. Lietman2802020-09-242025-02-03
Perfecting Refraction in India With Superior Service Models
School Model, Referral Model, Referral Model + Cost Recovery - Refractive Error
Not applicableCompletedSun Yat-sen University1622019-08-122024-10-30
Investigation of the Accuracy of a Low-cost, Portable, Autorefractor to Provide Well-tolerated Eyeglass Prescriptions
QuickSee refractive error assessment + glasses - Refractive Errors
Not applicableCompletedJohns Hopkins University4002017-12-152020-07-21
PROductivity Study of Presbyopia Elimination in Rural-dwellers (PROSPER)
Intervention group, Control Group - Presbyopia
Not applicableCompletedCongdon Nathan7512017-07-242017-12-27
Corneal Ulcer Prevention Through Health Education
Health Education - Corneal Ulcer
UnknownAravind Eye Care System982072014-12-012014-11-06
Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases
Tele-medicine, Conventional referral - Diabetic Retinopathy
Not applicableCompletedAravind Eye Care System8012014-05-012015-04-22
Clinical & Visual Outcomes of Collagen Cross Linking for Fungal Keratitis
collagen crosslinking group, Topical anti-fungal therapy - Mycotic Corneal Ulcer
Not applicableUnknownAravind Eye Care System202014-02-012014-12-31
Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection
Prednisolone acetate1%,, Prednisolone acetate1%, cyclosporine 2% - Corneal Graft Rejection
Not applicableUnknownAravind Eye Care System2002012-02-012014-08-01

Conditions studied

Corneal Ulcer (3)  ·  Acanthamoeba Keratitis (2)  ·  Refractive Errors (2)  ·  Diabetic Retinopathy (1)  ·  Glaucoma (1)  ·  Glaucoma, Open-Angle (1)  ·  Myopia (1)  ·  Ocular Hypertension (1)  ·  Presbyopia (1)

Interventions

Corneal Cross-Linking (3)  ·  Natamycin (2)  ·  Rose Bengal (2)  ·  Adrenal Cortex Hormones (1)  ·  Control Groups (1)  ·  Cyclosporine (1)  ·  Eyeglasses (1)  ·  Telemedicine (1)  ·  Voriconazole (1)  ·  chlorhexidine gluconate (1)  ·  polihexanide (1)  ·  prednisolone acetate (1)

Countries

India (13)  ·  Brazil (4)  ·  United States (4)  ·  United Kingdom (1)

Top investigators

Jennifer Rose-Nussbaumer, MD (3)  ·  Nicole Varnado, MPH (3)  ·  Nathan Congdon (2)  ·  Tom Lietman, MD (2)  ·  Astrid Fletcher, MSc, PhD (1)  ·  David Friedman, MD, MPH, PhD (1)  ·  Dr. Venkatesh Prajna, DNB,FRCS (1)  ·  Dr.Anita Raghavan (1)  ·  Gerami D Seitzman, MD (1)  ·  Gerami Seitzman, MD (1)  ·  Jennifer Steger, PhD (1)  ·  Jeremy Keenan, MD, MPH (1)  ·  Priya Adhisesha Reddy (1)  ·  Ramasamy Kim, DO, DNB (1)  ·  Sanil Joseph, MHA, MSc (1)

Results publications

PMID 21508106, PMID 23109740, PMID 25841317, PMID 26190438, PMID 30049615, PMID 31070699, PMID 32557558, PMID 34901464, PMID 34942106, PMID 38112645, PMID 39011096, PMID 39192339, PMID 40705354, PMID 41561665, PMID 42348235

NIH funding

UG1EY028518 (2), UG1EY033284 (1)